Smead Capital Management Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
DISCK
Discovery, Inc. Series C Common Stock
DISCK
|
+$45.4M |
| 2 |
CLR
CONTINENTAL RESOURCES INC.
CLR
|
+$36.9M |
| 3 |
D.R. Horton
DHI
|
+$27.4M |
| 4 |
eBay
EBAY
|
+$21.3M |
| 5 |
ConocoPhillips
COP
|
+$20.3M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Ulta Beauty
ULTA
|
+$21.4M |
| 2 |
Walt Disney
DIS
|
+$9.24M |
| 3 |
Warner Bros
WBD
|
+$3.54M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Consumer Discretionary | 24.35% |
| 2 | Financials | 18.85% |
| 3 | Healthcare | 12.66% |
| 4 | Real Estate | 9.41% |
| 5 | Energy | 7.08% |
Similar funds
Smead Capital Management's Q2 2021 Portfolio in Review
As of Q2 2021, Smead Capital Management held 36 positions worth $2.86B, up 26% from $2.27B the previous quarter. Its ten largest holdings account for 54% of the portfolio.
Smead Capital Management deployed $361M of net new capital in Q2 2021, opening 1 new position and adding to 32 existing holdings. Its largest new stake was Organon & Co: 171,855 shares worth $5.2M.
By sector, the portfolio is most concentrated in Consumer Discretionary at 24% of assets, down from 26% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was Walt Disney, an estimated $9.24M trimmed.
- Smead Capital Management's largest Q2 2021 buy was Organon & Co: 171,855 shares worth $5.2M.
- Smead Capital Management added most to Discovery, Inc. Series C Common Stock in Q2 2021, an estimated $45.4M increase.
- Smead Capital Management's biggest Q2 2021 reduction was Walt Disney, cutting an estimated $9.24M.
- Smead Capital Management fully exited Ulta Beauty in Q2 2021, selling an estimated $21.4M.
- Smead Capital Management's ten largest holdings make up 54% of its $2.86B portfolio in Q2 2021.
- Smead Capital Management opened 1 new position and closed 1 in Q2 2021.
- Smead Capital Management's portfolio value rose 26% quarter-over-quarter to $2.86B.
Based on Smead Capital Management's 13F filing for Q2 2021, filed 30 Jul 2021.